The largest trial involving DSIP to date, which included a total of 107 volunteers, reported that the peptide was generally well-tolerated with mostly minor side effects, which included [8]: Low blood pressure Increased sweating Headache Nausea Vertigo Considering that the drop in blood pressure was reported as moderate to severe in some patients, researchers should consider hypotension as a potentially exclusionary criterion for DSIP research
Some research shows that stopping semaglutide too soon may lead to regaining the weight you lost while taking the medication
Vigorously wipe the rubber stopper of both the GHK-Cu vial and the BAC water vial with an alcohol prep pad
The use of glutathione suppositories extends to reducing inflammation, enhancing skin health, and mitigating the risk of certain types of cancer
CB1 activity (agonist) slows...things.down
Conclusions Our findings demonstrate that screening potential natural products through an AD-related pathway-gene network is a promising strategy for discovering novel therapeutics for AD
